JMKX 003162
Alternative Names: JMKX-003162Latest Information Update: 07 Jun 2022
At a glance
- Originator Jemincare
- Class Antineoplastics; Small molecules
- Mechanism of Action Intercellular signalling peptide and protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Glioma; Renal cancer
Most Recent Events
- 28 May 2022 Early research in Glioma in China (unspecified route) (Jemincare pipeline, May 2022)
- 28 May 2022 Early research in Renal cancer in China (unspecified route) (Jemincare pipeline, May 2022)